Why Is Apimeds Pharmaceuticals US Stock (APUS) Up Today?
Apimeds Pharmaceuticals US stock rallied after the company reached a deal with AQUAE to manage AQUAEChain.
Apimeds Pharmaceuticals Us Inc. (APUS)
Market is closed
Sector: Pharmaceutical Preparations
Hedge Fund Popularity
Hedge Fund Holdings
Filing Period:
Last updated on based on SEC 13F filings Last update:
| No. | Hedge Fund | Shares | Value | Activity | % Port |
|---|---|---|---|---|---|
| 1. | Renaissance Technologies Jim Simons | 0 | $0 | 0% |
Insider Trading: Purchases See All
| Insider | Price | Amount | Total Value | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $1.86 | 7,730 | $14,377.80 | 27,500 | 2025-05-14 | Filing | |
| $1.82 | 19,770 | $35,981.40 | 19,770 | 2025-05-13 | Filing | |
| $1.99 | 28,500 | $56,715.00 | 643,885 | 2025-05-12 | Filing | |
| $4.00 | 500,000 | $2,000,000.00 | 1,984,616 | 2025-05-12 | Filing |
Institutional Investors' Holdings
Filing Period: Filing is Ongoing
| No. | Name | Shares | Value | % Port |
|---|---|---|---|---|
| 1. | 6,429 | $32,145 | 0% | |
| 2. | 1 | $5 | 0% | |
| 3. | 0 | $0 | 0% | |
| 4. | 0 | $0 | 0% |
News See All
Hedge Fund Resource Center